602 results on '"Matthews, Gail V"'
Search Results
2. SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa
- Author
-
Papot, Emmanuelle, Tovar-Sanchez, Tamara, Woods, Joana, Thaurignac, Guillaume, Eriobu, Nnakelu, Borok, Margaret, Kaplan, Richard, Avihingsanon, Anchalee, Azwa, Iskandar, Grinsztejng, Beatriz, Kumarasamy, Nagalingeswaran, Sokhela, Simiso, Mpoudi-Etame, Mireille, Arriaga, Maria, Jacoby, Simone, Matthews, Gail V., Losso, Marcelo H., Khoo, Saye, Calmy, Alexandra, Kouanfack, Charles, Ayouba, Ahidjo, Petoumenos, Kathy, Venter, W.D.Francois, Delaporte, Eric, and Polizzotto, Mark N.
- Published
- 2024
- Full Text
- View/download PDF
3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
- Author
-
Abel, Laurent, Aiuti, Alessandro, Al-Muhsen, Saleh, Al-Mulla, Fahd, Amara, Ali, Anderson, Mark S., Andreakos, Evangelos, Arias, Andrés A., Arkin, Lisa M., Feldman, Hagit Baris, Bastard, Paul, Belot, Alexandre, Biggs, Catherine M., Bogunovic, Dusan, Bolze, Alexandre, Bondarenko, Anastasiia, Borghesi, Alessandro, Bousfiha, Ahmed A., Brodin, Petter, Bryceson, Yenan, Butte, Manish J., Casanova, Jean-Laurent, Casari, Giorgio, Christodoulou, John, Cobat, Aurélie, Colobran, Roger, Condino-Neto, Antonio, Constantinescu, Stefan N., Cooper, Megan A., Dalgard, Clifton L., Desai, Murkesh, Drolet, Beth A., Duval, Xavier, El Baghdadi, Jamila, Eloy, Philippine, Espinosa-Padilla, Sara, Fellay, Jacques, Flores, Carlos, Franco, José Luis, Froidure, Antoine, Gorochov, Guy, Gregersen, Peter K., Grimbacher, Bodo, Haerynck, Filomeen, Hagin, David, Halwani, Rabih, Hammarström, Lennart, Heath, James R., Hsieh, Elena W.Y., Husebye, Eystein, Imai, Kohsuke, Itan, Yuval, Jouanguy, Emmanuelle, Kaja, Elżbieta, Karamitros, Timokratis, Kisand, Kai, Ku, Cheng-Lung, Lau, Yu-Lung, Ling, Yun, Lucas, Carrie L., Maniatis, Tom, Mansouri, Davood, Maródi, László, Mentré, France, Meyts, Isabelle, Milner, Joshua D., Mironska, Kristina, Mogensen, Trine H., Morio, Tomohiro, Ng, Lisa F.P., Notarangelo, Luigi D., Novelli, Antonio, Novelli, Giuseppe, O'Farrelly, Cliona, Okada, Satoshi, Okamoto, Keisuke, Ozcelik, Tayfun, Pan-Hammarström, Qiang, Pape, Jean W., Perez de Diego, Rebeca, Perez-Tur, Jordi, Perlin, David S., Pesole, Graziano, Planas, Anna M., Prando, Carolina, Pujol, Aurora, Puel, Anne, Quintana-Murci, Lluis, Ramaswamy, Sathishkumar, Renia, Laurent, Resnick, Igor, Rodríguez-Gallego, Carlos, Sancho-Shimizu, Vanessa, Sediva, Anna, Seppänen, Mikko R.J., Shahrooei, Mohammad, Shcherbina, Anna, Slaby, Ondrej, Snow, Andrew L., Soler-Palacín, Pere, Soumelis, Vassili, Spaan, András N., Tancevski, Ivan, Tangye, Stuart G., Tayoun, Ahmad Abou, Temel, Şehime Gülsün, Thorball, Christian, Tiberghien, Pierre, Trouillet-Assant, Sophie, Turvey, Stuart E., Uddin, K. M. Furkan, Uddin, Mohammed J., van de Beek, Diederik, Vinh, Donald C., von Bernuth, Horst, Wauters, Joost, Zatz, Mayana, Zawadzki, Pawel, Zhang, Qian, Zhang, Shen-Ying, Bureau, Serge, Vacher, Yannick, Gysembergh-Houal, Anne, Demerville, Lauren, Benleulmi-Chaachoua, Abla, Abad, Sebastien, Abassi, Radhiya, Abdellaoui, Abdelrafie, Abdelmalek, Abdelkrim, Abdoul, Hendy, Abergel, Helene, Abeud, Fariza, Abgrall, Sophie, Abisror, Noemie, Adechian, Marylise, Aderdour, Nordine, Admane, Hakeem Farid, Adnet, Frederic, Afritt, Sara, Agostini, Helene, Aguilar, Claire, Agut, Sophie, Aiello, Tommaso Francesco, Kaci, Marc Ait, Oufella, Hafid Ait, Ajeenthiravasan, Gokula, Alauzy, Virginie, Alby-Laurent, Fanny, Allard, Lucie, Alyanakian, Marie-Alexandra, Borrero, Blanca Amador, Amam, Sabrina, Amrouche, Lucile, Andronikof, Marc, Anglicheau, Dany, Anguel, Nadia, Annane, Djillali, Aounzou, Mohammed, Aparicio, Caroline, Aratus, Gladys, Arlet, Jean-Benoit, Arzoine, Jeremy, Aslangul, Elisabeth, Assefi, Mona, Aubry, Adeline, Audiffred, Laetitia, Audureau, Etienne, Auger, Christelle Nathalie, Auregan, Jean-Charles, Awotar, Celine, Milla, Sonia Ayllon, Azan, Delphine, Azemar, Laurene, Azzouguen, Billal, Elrufaai, Marwa Bachir, Badsi, Aïda, Bakouboula, Prissile, Balcerowiak, Coline, Balde, Fanta, Baldivia, Elodie, Bangamingo, Eliane-Flore, Baptiste, Amandine, Baran-Marszak, Fanny, Barau, Caroline, Barget, Nathalie, Baronnet, Flore, Barthelemy, Romain, Baudel, Jean-Luc, Baudry, Camille, Baudry, Elodie, Beaugerie, Laurent, Belamri, Adel, Belaube, Nicolas, Belilita, Rhida, Bellassen, Pierre, Belmokhtar, Rawan, Beltran, Isabel, Benainous, Ruben, Benallaoua, Mourad, Benamouzig, Robert, Benbara, Amélie, Benhida, Jaouad, Benkhelouf, Anis, Benlagha, Jihene, Benmostafa, Chahinez, Benothmane, Skander, Bentifraouine, Miassa, Berard, Laurence, Bernier, Quentin, Berti, Enora, Bertier, Astrid, Berton, Laure, Bessis, Simon, Beurton, Alexandra, Bianco, Celine, Bianquis, Clara, Bidar, Frank, Blanche, Philippe, Blayau, Clarisse, Bleibtreu, Alexandre, Blin, Emmanuelle, Bloch-Queyrat, Coralie, Boissier, Marie-Christophe, Bollens, Diane, Bolzoni, Marion, Bompard, Rudy pierre, Bonnet, Nicolas, Bonnouvrier, Justine, Botha, Shirmonecrystal, Boucenna, Wissam, Bouchama, Fatiha, Bouchaud, Olivier, Bouchghoul, Hanane, Boudjebla, Taoueslylia, Boudjema, Noel, Bouffard, Catherine, Bougle, Adrien, Bouguerra, Meriem, Bouras, Leila, Bourcier, Agnes, Durand, Anne Bourgarit, Bourrier, Anne, Bouscarat, Fabrice, Bouvry, Diane, Bouziri, Nesrine, Bouzrara, Ons, Bribier, Sarah, Brugier, Delphine, Brunel, Melanie, Bui, Eida, Buisson, Anne, Bukreyeva, Iryna, Bureau, Côme, Cadranel, Jacques, Cailhol, Johann, Calin, Ruxandra, Vega, Clara Campos, Canavaggio, Pauline, Cancella, Marta, Cantin, Delphine, Cao, Albert, Carbillon, Lionel, Carlier, Nicolas, Cassard, Clementine, Castor, Guylaine, Cauchy, Marion, Cha, Olivier, Chaigne, Benjamin, Challal, Salima, Champion, Karine, Chariot, Patrick, Chas, Julie, Chauveau, Simon, Chauvin, Anthony, Chauvin, Clement, Chavarot, Nathalie, Chebbout, Kamélia, Cherai, Mustapha, Cherubini, Ilaria, Chevalier, Amelie, Chiarabini, Thibault, Chinet, Thierry, Chocron, Richard, Choinier, Pascaline, Chommeloux, Juliette, Choquet, Christophe, Choupeaux, Laure, Chousterman, Benjamin, Ciocan, Dragosmarius, Clarke, Ada, Clavere, Gaëlle, Clavier, Florian, Clement, Karine, Clerc, Sebastien, Cohen, Yves, Cohen, Fleur, Cohen, Adrien, Coilly, Audrey, Colboc, Hester, Colin, Pauline, Collet, Magalie, Comarmond, Chloé, Combacon, Emeline, Combes, Alain, Comparon, Celine, Constantin, Jean-Michel, Cordel, Hugues, Cordier, Anne-Gael, Costantini, Adrien, Chalumeau, Nathalie Costedoat, Couffignal, Camille, Coupeau, Doriane, Creange, Alain, Lamarre, Yannie Cuvillier, Da Silveira, Charlène, Guibal El Kayani, Sandrine Dautheville, De Castro, Nathalie, De Rycke, Yann, Del Pozo, Lucie, Delannoy, Quentin, Delay, Mathieu, Deleris, Robin, Delforge, Juliette, Delphine, Laëtitia, Demare, Noemie, Demeret, Sophie, Demoule, Alexandre, Deniau, Aurore, Depret, François, Derolez, Sophie, Derradji, Ouda, Derridj, Nawal, Descamps, Vincent, Deschamps, Lydia, Desconclois, Celine, Desnos, Cyrielle, Desongins, Karine, Dhote, Robin, Diallo, Benjamin, Didier, Morgane, Diemer, Myriam, Diez, Stephane, Djadi-Prat, Juliette, Djamouri Monnory, Fatima-Zohra, Djebara, Siham, Djebra, Naoual, Djietcheu, Minette, Djillali, Hadjer, Djouadi, Nouara, Donneger, Severine, Santos, Catarina Dos, Dournon, Nathalie, Dres, Martin, Droctove, Laura, Drogrey, Marie, Dropy, Margot, Drouet, Elodie, Dubosq, Valérie, Dubreucq, Evelyne, Dubus, Estelle, Duchemann, Boris, Duchenoy, Thibault, Dudoignon, Emmanuel, Dufau, Romain, Dumas, Florence, Duran, Clara, Duron, Emmanuelle, Durrbach, Antoine, Duvivier, Claudine, Ebstein, Nathan, El Khalifa, Jihane, Elabbadi, Alexandre, Elie, Caroline, Ernotte, Gabriel, Esling, Anne, Etienne, Martin, Eyer, Xavier, Fartoukh, Muriel Sarah, Fayali, Takoua, Fermaut, Marion, Fiorentino, Arianna, Fliss, Souha, Fournier, Marie-Céline, Fournier, Benjamin, Francois, Hélène, Freynet, Olivia, Frigout, Yvann, Fromont, Isaure, Fuentes, Axelle, Furet, Thomas, Galand, Joris, Garnier, Marc, Gaubert, Agnes, Gaudry, Stéphane, Gaugain, Samuel, Gauthier, Damien, Gautier, Maxime, Georgin-Lavialle, Sophie, Geromin, Daniela, Ghalayini, Mohamed, Ghaleh, Bijan, Ghezal, Myriam, Gibelin, Aude, Gimeno, Linda, Girard, Benoit, Leprieur, Bénédicte Giroux, Gomes, Doryan, Gomes-Pires, Elisabete, Gouge, Anne, Gouja, Amel, Goulet, Helene, Goupil, Sylvain, De Bouille, Jeanne Goupil, Gras, Julien, Greffe, Segolene, Grimaldi, Lamiae, Guedeney, Paul, Guidet, Bertrand, Guillo, Matthias, Gulczynski, Mariechristelle, Hadjam, Tassadit, Haguenauer, Didier, Hammal, Soumeya, Hammoudi, Nadjib, Hanon, Olivier, Harrois, Anarole, Hausfater, Pierre, Hautem, Coraline, Hekimian, Guillaume, Heming, Nicholas, Hermine, Olivier, Ho, Sylvie, Houllier, Marie, Huot, Benjamin, Huscenot, Tessa, Saied, Wafa Ibn, Ikherbane, Ghilas, Imarazene, Meriem, Ingiliz, Patrick, Iratni, Lina, Jaureguiberry, Stephane, Jean-Marc, Jean-Francois, Jeyarajasingham, Deleena, Jouany, Pauline, Jouis, Veronique, Jourdaine, Clement, Kafif, Ouifiya, Kallala, Rim, Katsahian, Sandrine, Kelesyan, Lilit, Keo, Vixra, Ketz, Flora, Khamis, Warda, Khelili, Enfel, Khellaf, Mehdi, Kotokpo Youkou, Christy Gaëlla, Kounis, Ilias, Kpalma, Gaelle, Krause, Jessica, Labbe, Vincent, Lacombe, Karine, Lacorte, Jean-Marc, Lafont, Anne Gaelle, Lafont, Emmanuel, Lagha, Lynda, Lamhaut, Lionel, Lancelot, Aymeric, Landman, Cecilia, Lanternier, Fanny, Larcheveque, Cecile, Combe, Caroline Lascoux, Lassel, Ludovic, Laverdant, Benjamin, Lavergne, Christophe, Lavillegrand, Jean-Rémi, Lazureanu, Pompilia, Le Guennec, Loïc, Leberre, Lamia, Leblanc, Claire, Leboyer, Marion, Lecomte, Francois, Lecorre, Marine, Leenhardt, Romain, Lefebvre, Marylou, Lefebvre, Bénédicte, Legendre, Paul, Leger, Anne, Legros, Laurence, Legrosse, Justyna, Lehuunghia, Sébastien, Lemarec, Julien, Leporrier-Ext, Jeremie, Lesein, Manon, Lesur, Hubert, Levy, Vincent, Levy, Albert, Lopes, Edwige, Lopes, Amanda, Lopez, Vanessa, Lopinto, Julien, Lortholary, Olivier, Louadah, Badr, Loze, Bénédicte, Lucas, Marie-Laure, Lucasamichi, Axelle, Luong, Liem Binh, Magazimama-Ext, Arouna, Maingret, David, Mameri, Lakhdar, Manivet, Philippe, Mansouri, Cylia, Marcault, Estelle, Marey, Jonathan, Marin, Nathalie, Marois, Clémence, Martin, Olivier, Martineau, Lou, Martinez-Lopez, Cannelle, Martyniuck, Pierre, De Farcy, Pauline Mary, Marzouk, Nessrine, Masmoudi, Rafik, Mebazaa, Alexandre, Mechai, Frédéric, Mecozzi, Fabio, Mediouni, Chamseddine, Megarbane, Bruno, Meghadecha, Mohamed, Mejean, Élodie, Mekinian, Arsene, Abdelhadi, Nour Mekki, Mekni, Rania, Meliti, Thinhinan Sabrina, Lima, Breno Melo, Meng, Paris, Merbah, Soraya, Messani, Fadhila, Messaoudi, Yasmine, Mewasing, Baboo-Irwinsingh, Meziane, Lydia, Michelot-Burger, Carole, Mignot, Françoise, Minka, Fadi Hillary, Miyara, Makoto, Moine, Pierre, Molina, Jean-Michel, Montegnies-Boulet, Anaïs, Monti, Alexandra, Montlahuc, Claire, Montout, Anne-Lise, Moores, Alexandre, Morbieu, Caroline, Mortelette, Helene, Mouly, Stéphane, Muzaffar, Rosita, Nacerddine, Cherifa Iness, Nadal, Marine, Nadif, Hajer, Nassarmadji, Kladoum, Natella, Pierre, Ndingamondze, Sandrine, Neraal, Stefan, Nguyen, Caroline, N'Guyen, Bao, Larmurier, Isabelle Nion, Nlomenyengue, Luc, Noel, Nicolas, Nunes, Hilario, Omar, Edris, Ouazene, Zineb, Ouedraogo, Elise, Ouelaa, Wassila, Oukhedouma, Anissa, Amara, Yasmina Ould, Oya, Herve, Oziel, Johanna, Padilla, Thomas, Paillaud, Elena, Paiva, Solenne, Parfait, Beatrice, Parize, Perrine, Parizot, Christophe, Parrot, Antoine, Pavot, Arthur, Peaudecerf, Laetitia, Pene, Frédéric, Pepin, Marion, Pernet, Julie, Pernin, Claire, Petit, Mylène, Peyrony, Olivier, Pietri, Marie-Pierre, Pietri, Olivia, De Chambrun, Marc Pineton, Pinson, Michelle, Pintado, Claire, Piquard, Valentine, Pires, Christine, Planquette, Benjamin, Poirier, Sandrine, Pomel, Anne-Laure, Pons, Stéphanie, Ponscarme, Diane, Pourcelot, Annegaelle, Pourcher, Valérie, Pouvaret, Anne, Prever, Florian, Previlon, Miresta, Prevost, Margot, Provoost, Marie-Julie, Quemeneur, Cyril, Rafat, Cédric, Rami, Agathe, Ranque, Brigitte, Raphael, Maurice, Raphalen, Jean Herle, Rastoin, Anna, Raux, Mathieu, Rebai, Amani, Reby, Michael, Regent, Alexis, Regrag, Asma, Resche-Rigon, Matthieu, Ressaire, Quentin, Richard, Christian, Richard, Mariecaroline, Robert, Maxence, Rohaut, Benjamin, Rolland-Debord, Camille, Ropers, Jacques, Roque-Afonso, Anne-Marie, Rosso, Charlotte, Rousseaux, Mélanie, Rousseaux, Nabila, Roux, Swasti, Roux, Lorène, Rouzaud, Claire, Rozes, Antoine, Rubenstein, Emma, Sabate, Jean-Marc, Sabet, Sheila, Sacleux, Sophie-Caroline, Kermanach, Nathalie Saidenberg, Saliba, Faouzi, Salmon, Dominique, Savale, Laurent, Savary, Guillaume, Sberro, Rebecca, Scemla, Anne, Schlemmer, Frederic, Schwartz, Mathieu, Sedfi, Saïd, Sefir-Kribel, Samia, Seksik, Philippe, Sellier, Pierre, Selves, Agathe, Sembach, Nicole, Semerano, Luca, Senat, Marie-Victoire, Sene, Damien, Serris, Alexandra, Sese, Lucile, Sghiouar, Naima, Sigaux, Johanna, Siguier, Martin, Silvain, Johanne, Simon, Noémie, Simon, Tabassome, Skandri, Lina Innes, Slimani, Miassa, Snauwaert, Aurélie, Sokol, Harry, Soliman, Heithem, Soltani, Nisrine, Soyer, Benjamin, Steg, Gabriel, Suarez, Lydia, Szwebel, Tali-Anne, Taffame, Kossi, Tandjaoui-Lambiotte, Yacine, Tantet, Claire, Tateo, Mariagrazia, Theodose, Igor, Thiebaud, Pierre clement, Thomas, Caroline, Tiercelet, Kelly, Tisserand, Julie, Tomczak, Carole, Torelino, Krystel, Touam-Ext, Fatima, Toumi, Lilia, Toury, Gustave, Toy-Miou, Mireille, Dinh Thanh Lien, Olivia Tran, Trandinh, Alexy, Treluyer, Jean-Marc, Trinque, Baptiste, Truchot, Jennifer, Tubach, Florence, Tubiana, Sarah, Tunesi, Simone, Turpin, Matthieu, Turpin, Agathe, Urbina, Tomas, Narvaez, Rafael Usubillaga, Uzunhan, Yurdagul, Vaittinadaayar, Prabakar, Valent, Arnaud, Valentian, Maelle, Valin, Nadia, Vallet, Hélène, Vaz, Marina, Vazquezibarra, Miguel-Alejandro, Vedie, Benoit, Velly, Laetitia, Verstuyft, Celine, Viallette, Cedric, Vicaut, Eric, Vignes, Dorothee, Vimpere, Damien, Virlouvet, Myriam, Voiriot, Guillaume, Voisot, Lena, Weiss, Emmanuel, Weiss, Nicolas, Winchenne, Anaïs, Yordanov, Youri, Zafrani, Lara, Zaidan, Mohamad, Zaidi, Wissem, Zak, Cathia, Zarhrate-Ghoul, Aida, Zatout, Ouassila, Zeino, Suzanne, Zeitouni, Michel, Zemirli, Naïma, Zerah, Lorene, Zia, Ounsa, Ziol, Marianne, Zolario, Oceane, Zuber, Julien, Andrejak, Claire, Angoulvant, François, Bachelet, Delphine, Bartoli, Marie, Basmaci, Romain, Behillil, Sylvie, Beluze, Marine, Benkerrou, Dehbia, Bhavsar, Krishna, Bouadma, Lila, Bouchez, Sabelline, Bouscambert, Maude, Cervantes-Gonzalez, Minerva, Chair, Anissa, Chirouze, Catherine, Coelho, Alexandra, Couffin-Cadiergues, Sandrine, d’Ortenzio, Eric, Debray, Marie-Pierre, Deconinck, Laurene, Deplanque, Dominique, Descamps, Diane, Desvallée, Mathilde, Diallo, Alpha, Diouf, Alphonsine, Dorival, Céline, Dubos, François, Elharrar, Brigitte, Enouf, Vincent, Esperou, Hélène, Esposito-Farese, Marina, Etienne, Manuel, Devouge, Eglantine Ferrand, Gault, Nathalie, Gaymard, Alexandre, Ghosn, Jade, Gigante, Tristan, Gilg, Morgane, Guedj, Jérémie, Hoctin, Alexandre, Hoffmann, Isabelle, Houas, Ikram, Hulot, Jean-Sébastien, Jaafoura, Salma, Kaguelidou, Florentia, Kali, Sabrina, Khalil, Antoine, Khan, Coralie, Laouénan, Cédric, Laribi, Samira, Le, Minh, Le Hingrat, Quentin, Le Mestre, Soizic, Le Nagard, Hervé, Lescure, François-Xavier, Letrou, Sophie, Levy, Yves, Lina, Bruno, Lingas, Guillaume, Lucet, Jean-Christophe, Malvy, Denis, Mambert, Marina, Meziane, Amina, Mouquet, Hugo, Mullaert, Jimmy, Neant, Nadège, Nguyen, Duc, Noret, Marion, Nseir, Saad, Papadopoulos, Aurélie, Paul, Christelle, Peiffer-Smadja, Nathan, Perpoint, Thomas, Petrov-Sanchez, Ventzislava, Peytavin, Gilles, Pham, Huong, Picone, Olivier, Puéchal, Oriane, Rabaud, Christian, Rosa-Calatrava, Manuel, Rossignol, Bénédicte, Rossignol, Patrick, Roy, Carine, Schneider, Marion, Su, Richa, Tardivon, Coralie, Tellier, Marie-Capucine, Téoulé, François, Terrier, Olivier, Timsit, Jean-François, Tual, Christelle, Van Der Werf, Sylvie, Vanel, Noémie, Veislinger, Aurélie, Visseaux, Benoit, Wiedemann, Aurélie, Yazdanpanah, Yazdan, Alavoine, Loubna, Burdet, Charles, Charpentier, Charlotte, Dechanet, Aline, Ecobichon, Jean-Luc, Frezouls, Wahiba, Houhou, Nadhira, Lehacaut, Jonathan, Manchon, Pauline, Nouroudine, Mariama, Quintin, Caroline, Thy, Michael, van der Werf, Sylvie, Vignali, Valérie, Chahine, Abir, Waucquier, Nawal, Migaud, Maria-Claire, Djossou, Félix, Mergeay-Fabre, Mayka, Lucarelli, Aude, Demar, Magalie, Bruneau, Léa, Gérardin, Patrick, Maillot, Adrien, Payet, Christine, Laviolle, Bruno, Laine, Fabrice, Paris, Christophe, Desille-Dugast, Mireille, Fouchard, Julie, Pistone, Thierry, Perreau, Pauline, Gissot, Valérie, Goas, Carole L.E., Montagne, Samatha, Richard, Lucie, Bouiller, Kévin, Desmarets, Maxime, Meunier, Alexandre, Bourgeon, Marilou, Lefévre, Benjamin, Jeulin, Hélène, Legrand, Karine, Lomazzi, Sandra, Tardy, Bernard, Gagneux-Brunon, Amandine, Bertholon, Frédérique, Botelho-Nevers, Elisabeth, Kouakam, Christelle, Nicolas, Leturque, Roufai, Layidé, Amat, Karine, Espérou, Hélène, Hendou, Samia, Foti, Giuseppe, Citerio, Giuseppe, Contro, Ernesto, Pesci, Alberto, Valsecchi, Maria Grazia, Cazzaniga, Marina, Bellani, Giacomo, Abad, Jorge, Accordino, Giulia, Angelini, Micol, Aguilera-Albesa, Sergio, Aguiló-Cucurull, Aina, Özkan, Esra Akyüz, Darazam, Ilad Alavi, Roblero Albisures, Jonathan Antonio, Aldave, Juan C., Ramos, Miquel Alfonso, Khan, Taj Ali, Aliberti, Anna, Nadji, Seyed Alireza, Alkan, Gulsum, AlKhater, Suzan A., Allardet-Servent, Jerome, Allende, Luis M., Alonso-Arias, Rebeca, Alshahrani, Mohammed S., Alsina, Laia, Amoura, Zahir, Antolí, Arnau, Arrestier, Romain, Aubart, Mélodie, Auguet, Teresa, Avramenko, Iryna, Aytekin, Gökhan, Azot, Axelle, Bahram, Seiamak, Bajolle, Fanny, Baldanti, Fausto, Baldolli, Aurélie, Ballester, Maite, Barrou, Benoit, Barzaghi, Federica, Basso, Sabrina, Bayhan, Gulsum Iclal, Bezrodnik, Liliana, Bilbao, Agurtzane, Blanchard-Rohner, Geraldine, Blanco, Ignacio, Blandinières, Adeline, Blázquez-Gamero, Daniel, Bloomfield, Marketa, Bolivar-Prados, Mireia, Borie, Raphael, Botdhlo-Nevers, Elisabeth, Bousquet, Aurore, Boutolleau, David, Bouvattier, Claire, Boyarchuk, Oksana, Bravais, Juliette, Briones, M. Luisa, Brunner, Marie-Eve, Bruno, Raffaele, Bueno, Maria Rita P., Bukhari, Huda, Bustamante, Jacinta, Cáceres Agra, Juan José, Capra, Ruggero, Carapito, Raphael, Carrabba, Maria, Casasnovas, Carlos, Caseris, Marion, Cassaniti, Irene, Castelle, Martin, Castelli, Francesco, Castillo de Vera, Martín, Castro, Mateus V., Catherinot, Emilie, Celik, Jale Bengi, Ceschi, Alessandro, Chalumeau, Martin, Charbit, Bruno, Boulanger, Cécile, Clavé, Père, Clotet, Bonaventura, Codina, Anna, Comarmond, Cloé, Comoli, Patrizia, Corsico, Angelo G., Coşkuner, Taner, Cvetkovski, Aleksandar, Cyrus, Cyril, Dalmau, David, Danion, François, Darley, David Ross, Das, Vincent, Dauby, Nicolas, Dauger, Stéphane, De Munte, Paul, de Pontual, Loic, Dehban, Amin, Delplancq, Geoffroy, Desguerre, Isabelle, Di Sabatino, Antonio, Diehl, Jean-Luc, Dobbelaere, Stephanie, Domínguez-Garrido, Elena, Dubost, Clément, Ekwall, Olov, Bozdemir, Şefika Elmas, Elnagdy, Marwa H., Emiroglu, Melike, Endo, Akifumi, Erdeniz, Emine Hafize, Aytekin, Selma Erol, Etxart Lasa, Maria Pilar, Euvrard, Romain, Fabio, Giovanna, Faivre, Laurence, Falck, Antonin, Fartoukh, Muriel, Faure, Morgane, Arquero, Miguel Fernandez, Ferrer, Ricard, Ferreres, Jose, Francois, Bruno, Fumadó, Victoria, Fung, Kitty S.C., Fusco, Francesca, Gagro, Alenka, Solis, Blanca Garcia, Garçon, Pierre, Gaussem, Pascale, Gayretli, Zeynep, Gil-Herrera, Juana, Gilardin, Laurent, Gatineau, Audrey Giraud, Girona-Alarcón, Mònica, Cifuentes Godínez, Karen Alejandra, Goffard, Jean-Christophe, Gonzales, Nacho, Gonzalez-Granado, Luis I., González-Montelongo, Rafaela, Guerder, Antoine, Gülhan, Belgin, Gumucio, Victor Daniel, Hanitsch, Leif Gunnar, Gunst, Jan, Gut, Marta, Hadjadj, Jérôme, Hancerli, Selda, Hariyan, Tetyana, Hatipoglu, Nevin, Heppekcan, Deniz, Hernandez-Brito, Elisa, Ho, Po-ki, Holanda-Peña, María Soledad, Horcajada, Juan P., Hraiech, Sami, Humbert, Linda, Hung, Ivan F.N., Iglesias, Alejandro D., Íñigo-Campos, Antonio, Jamme, Matthieu, Arranz, María Jesús, Jimeno, Marie-Thérèse, Jordan, Iolanda, Kanık-Yüksek, Saliha, Kara, Yalcin, Karahan, Aydın, Karbuz, Adem, Yasar, Kadriye Kart, Kasapcopur, Ozgur, Kashimada, Kenichi, Keles, Sevgi, Demirkol, Yasemin Kendir, Kido, Yasutoshi, Kizil, Can, Kılıç, Ahmet Osman, Klocperk, Adam, Koutsoukou, Antonia, Król, Zbigniew J., Ksouri, Hatem, Kuentz, Paul, Kwan, Arthur M.C., Kwan, Yat Wah M., Kwok, Janette S.Y., Lagier, Jean-Christophe, Lam, David S.Y., Lampropoulou, Vicky, Le Bourgeois, Fleur, Leo, Yee-Sin, Lopez, Rafael Leon, Leung, Daniel, Levin, Michael, Levy, Michael, Lévy, Romain, Li, Zhi, Lilleri, Daniele, Adrian Bolanos Lima, Edson Jose, Linglart, Agnes, López-Collazo, Eduardo, Lorenzo-Salazar, José M., Louapre, Céline, Lubetzki, Catherine, Lung, Kwok-Cheung, Luyt, Charles-Edouard, Lye, David C., Magnone, Cinthia, Marchioni, Enrico, Marioli, Carola, Marjani, Majid, Marques, Laura, Pereira, Jesus Marquez, Martín-Nalda, Andrea, Pueyo, David Martínez, Martinez-Picado, Javier, Marzana, Iciar, Mata-Martínez, Carmen, Mathian, Alexis, Matos, Larissa R.B., Matthews, Gail V., Mayaux, Julien, McLaughlin-Garcia, Raquel, Meersseman, Philippe, Mège, Jean-Louis, Mekontso-Dessap, Armand, Melki, Isabelle, Meloni, Federica, Meritet, Jean-François, Merlani, Paolo, Akcan, Özge Metin, Mezidi, Mehdi, Migeotte, Isabelle, Millereux, Maude, Million, Matthieu, Mirault, Tristan, Mircher, Clotilde, Mirsaeidi, Mehdi, Mizoguchi, Yoko, Modi, Bhavi P., Mojoli, Francesco, Moncomble, Elsa, Melián, Abián Montesdeoca, Martinez, Antonio Morales, Morandeira, Francisco, Morange, Pierre-Emmanuel, Mordacq, Clémence, Morelle, Guillaume, Mouly, Stéphane J., Muñoz-Barrera, Adrián, Nafati, Cyril, Nagashima, Shintaro, Nakagama, Yu, Neven, Bénédicte, Neves, João Farela, Ng, Yuk-Yung, Hubert Nielly, Medina, Yeray Novoa, Cuadros, Esmeralda Nuñez, Karabela, Semsi Nur, Ocejo-Vinyals, J. Gonzalo, Oualha, Mehdi, Ouedrani, Amani, Özçelik, Tayfun, Ozkaya-Parlakay, Aslinur, Pagani, Michele, Papadaki, Maria, Parola, Philippe, Pascreau, Tiffany, Paul, Stéphane, Paz-Artal, Estela, Pedraza, Sigifredo, González Pellecer, Nancy Carolina, Pellegrini, Silvia, Pérez de Diego, Rebeca, Pérez-Fernández, Xosé Luis, Philippe, Aurélien, Philippot, Quentin, Picod, Adrien, Pineton de Chambrun, Marc, Piralla, Antonio, Planas-Serra, Laura, Ploin, Dominique, Poissy, Julien, Poncelet, Géraldine, Poulakou, Garyphallia, Pouletty, Marie S., Pourshahnazari, Persia, Qiu-Chen, Jia Li, Quentric, Paul, Rambaud, Thomas, Raoult, Didier, Raoult, Violette, Rebillat, Anne-Sophie, Redin, Claire, Resmini, Léa, Ricart, Pilar, Richard, Jean-Christophe, Rigo-Bonnin, Raúl, Rivet, Nadia, Rivière, Jacques G., Rocamora-Blanch, Gemma, Rodero, Mathieu P., Rodrigo, Carlos, Rodriguez, Luis Antonio, Rodriguez-Gallego, Carlos, Rodriguez-Palmero, Agustí, Romero, Carolina Soledad, Rothenbuhler, Anya, Roux, Damien, Rovina, Nikoletta, Rozenberg, Flore, Ruch, Yvon, Ruiz, Montse, Ruiz del Prado, Maria Yolanda, Ruiz-Rodriguez, Juan Carlos, Sabater-Riera, Joan, Saks, Kai, Salagianni, Maria, Sanchez, Oliver, Sánchez-Montalvá, Adrián, Sánchez-Ramón, Silvia, Schidlowski, Laire, Schluter, Agatha, Schmidt, Julien, Schmidt, Matthieu, Schuetz, Catharina, Schweitzer, Cyril E., Scolari, Francesco, Seijo, Luis, Seminario, Analia Gisela, Seng, Piseth, Senoglu, Sevtap, Seppänen, Mikko, Llovich, Alex Serra, Siguret, Virginie, Siouti, Eleni, Smadja, David M., Smith, Nikaia, Sobh, Ali, Solanich, Xavier, Solé-Violán, Jordi, Soler, Catherine, Sözeri, Betül, Stella, Giulia Maria, Stepanovskiy, Yuriy, Stoclin, Annabelle, Taccone, Fabio, Taupin, Jean-Luc, Tavernier, Simon J., Tello, Loreto Vidaur, Terrier, Benjamin, Thiery, Guillaume, Thorn, Karolina, Thumerelle, Caroline, Tipu, Imran, Tolstrup, Martin, Tomasoni, Gabriele, Toubiana, Julie, Alvarez, Josep Trenado, Triantafyllia, Vasiliki, Troya, Jesús, Tsang, Owen T.Y., Tserel, Liina, Tso, Eugene Y.K., Tucci, Alessandra, Tüter Öz, Şadiye Kübra, Ursini, Matilde Valeria, Utsumi, Takanori, Vabres, Pierre, Valencia-Ramos, Juan, Van Den Rym, Ana Maria, Vandernoot, Isabelle, Velez-Santamaria, Valentina, Zuniga Veliz, Silvia Patricia, Vidigal, Mateus C., Viel, Sébastien, Villain, Cédric, Vilaire-Meunier, Marie E., Villar-García, Judit, Vincent, Audrey, Van der Linden, Dimitri, Volokha, Alla, Vuotto, Fanny, Wauters, Els, Wu, Alan K.L., Wu, Tak-Chiu, Yahşi, Aysun, Yesilbas, Osman, Yildiz, Mehmet, Young, Barnaby E., Yükselmiş, Ufuk, Zecca, Marco, Zuccaro, Valentina, Van Praet, Jens, Lambrecht, Bart N., Van Braeckel, Eva, Bosteels, Cédric, Hoste, Levi, Hoste, Eric, Bauters, Fré, De Clercq, Jozefien, Heijmans, Catherine, Slabbynck, Hans, Naesens, Leslie, Florkin, Benoit, Young, Mary-Anne, Willis, Amanda, Lapuente-Suanzes, Paloma, de Andrés-Martín, Ana, Berkell, Matilda, Carelli, Valerio, Fiorentino, Alessia, Malhotra, Surbhi, Mattiaccio, Alessandro, Pippucci, Tommaso, Seri, Marco, Tacconelli, Evelina, van Agtmael, Michiel, Algera, Anne Geke, Appelman, Brent, van Baarle, Frank, Bax, Diane, Beudel, Martijn, Bogaard, Harm Jan, Bomers, Marije, Bonta, Peter, Bos, Lieuwe, Botta, Michela, de Brabander, Justin, de Bree, Godelieve, de Bruin, Sanne, Buis, David T.P., Bugiani, Marianna, Bulle, Esther, Chouchane, Osoul, Cloherty, Alex, Dijkstra, Mirjam, Dongelmans, Dave A., Dujardin, Romein W.G., Elbers, Paul, Fleuren, Lucas, Geerlings, Suzanne, Geijtenbeek, Theo, Girbes, Armand, Goorhuis, Bram, Grobusch, Martin P., Hafkamp, Florianne, Hagens, Laura, Hamann, Jorg, Harris, Vanessa, Hemke, Robert, Hermans, Sabine M., Heunks, Leo, Hollmann, Markus, Horn, Janneke, Hovius, Joppe W., de Jong, Menno D., Koning, Rutger, Lim, Endry H.T., van Mourik, Niels, Nellen, Jeaninne, Nossent, Esther J., Paulus, Frederique, Peters, Edgar, Pina-Fuentes, Dan A.I., van der Poll, Tom, Preckel, Bennedikt, Prins, Jan M., Raasveld, Jorinde, Reijnders, Tom, de Rotte, Maurits C.F. J., Schinkel, Michiel, Schultz, Marcus J., Schrauwen, Femke A.P., Schuurmans, Alex, Schuurmans, Jaap, Sigaloff, Kim, Slim, Marleen A., Smeele, Patrick, Smit, Marry, Stijnis, Cornelis S., Stilma, Willemke, Teunissen, Charlotte, Thoral, Patrick, Tsonas, Anissa M., Tuinman, Pieter R., van der Valk, Marc, Veelo, Denise P., Volleman, Carolien, de Vries, Heder, Vught, Lonneke A., van Vugt, Michèle, Wouters, Dorien, Zwinderman, A.H., Brouwer, Matthijs C., Wiersinga, W. Joost, Vlaar, Alexander P.J., Tompkins, Miranda F., Alba, Camille, Hupalo, Daniel N., Rosenberger, John, Sukumar, Gauthaman, Wilkerson, Matthew D., Zhang, Xijun, Lack, Justin, Oler, Andrew J., Dobbs, Kerry, Delmonte, Ottavia M., Danielson, Jeffrey J., Biondi, Andrea, Bettini, Laura Rachele, D’Angiò, Mariella, Beretta, Ilaria, Imberti, Luisa, Sottini, Alessandra, Quaresima, Virginia, Quiros-Roldan, Eugenia, Rossi, Camillo, Castagnoli, Riccardo, Montagna, Daniela, Licari, Amelia, Marseglia, Gian Luigi, Marchal, Astrid, Cirulli, Elizabeth T., Neveux, Iva, Bellos, Evangelos, Thwaites, Ryan S., Schiabor Barrett, Kelly M., Zhang, Yu, Nemes-Bokun, Ivana, Kalinova, Mariya, Catchpole, Andrew, Lack, Justin B., Chiu, Christopher, and Grzymski, Joseph J.
- Published
- 2024
- Full Text
- View/download PDF
4. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
- Author
-
Sargsyants, N., Suleymanova, L., Salkic, N., Simonova, M., Nemeth-Blazic, T., Mravcik, V., Kivimets, K., Salupere, R., Butsashvili, M., Soselia, G., Makara, M., Tolmane, I., Jancorienė, L., Stratulat, S., Flisiak, R., Gheorghe, L., Cernat, R., Lakhov, A., Stanevich, O., Jarcuska, P., Peck-Radosavljevic, M., Robaeys, G., Øvrehus, A., Foster, G., Sutinen, J., Farkkila, M., Rautiainen, H., Vuoti, S., Nikolova, D., Pawlotsky, J.M., Rockstroh, J., Sypsa, V., Papatheodoridis, G., Olafsson, S., Feeney, E., Teti, E., Seguin-Devaux, C., Pocock, J., Reiff, S., McDougall, N., Van der Valk, M., Dalgard, O., Tato Marinho, R., Dillon, J., Peters, E., Bojovic, K., Matičič, M., Kåberg, M., Bruggmann, P., Healy, B., Chong, V.H., Yi, S., Tucker, J., Pasaribu, L.R., Tanaka, J., Ashley, E.A., Abu Hassan, M.R., Mohammed, N.S., Chan, H.K., Gidaagaya, S., Kyi, K.P., Hyung Joon, K., Chin, B., Baladjay, P.C., Kao, J.H., Wansom, T., da Cruz, B., Flower, B., Ehsan, E., Al Mahtab, M., Khandu, L., Bhadoria, A.S., Alavi, M., KC, P., Hamid, S., Biryukov, S., Alymbaeva, D., Alaei, A., Bakieva, S., Flichman, D., Carmo, R.F., Valdez, E., Cortes, C.P., Contreras, F., Teran, E., Velez-Moller, P., Jagnarine, T., Mills, M., Goodman-Meza, D., Sánchez, J., Montenegro-Idrogo, J.J., Lugo Canales, A.M., Davy, J., Alexander, A., Gerona, S., Perazzo, R., Balak, D., Kelly-Hanku, A., Fineanganofo, A., Gane, E., Raymond, N., Debzi, N., Sridharan, K., Waked, I., Turner, D., Shibolet, O., Al Muzaini, A., El Nakib, M., Sheriff, D.S., Brahni, T., Essayagh, T., Essayagh, S., Hjaija, D., Al-Naamani, K., Sanai, F.M., Pasquale, H., Bedri, S., Chakroun, M., Ghrabi, A., Akarca, U.S., Falcao, V., Edmond Gbedo, S., Ouoba, S., Nyabenda, F., Rocher Mbella, M., Mahamat Moussa, A., Youssouf, T., Boniface, Y., Akilimali Shindano, T., Hamida, M.E., Mongo, A., Mapapa, C., Desalegn, H., Embinga, E.L.A., Ndow, G., Nartey, Y., Cisse, M., Djalo, M.A., Mugambi, M., Nyakowa, M., Jeuronlon, M.K., Ngoma, J., Manitrala Ramanampamonjy, R., Naik, K., Soyjaudah, M.D., Filipe, E., Nnakelu, E., Serumondo, J., Mbodj, M., Patino, M., Aalto, M.K., Waweru, P., Dagnra, A., Ocama, P., Maghimbi, A., Hamooya, B.M., Katsidzira, L., Rios, C., Thormann, M., Al Marzooqi, N., Al Rand, H.M., Francois, K., Hamoudi, W., Alkharty, M., Skripo, O., Uka, T., Marshall, Alison D, Willing, Alex R, Kairouz, Abe, Cunningham, Evan B, Wheeler, Alice, O’Brien, Nicholas, Perera, Vidura, Ward, John W, Hiebert, Lindsey, Degenhardt, Louisa, Hajarizadeh, Behzad, Colledge, Samantha, Hickman, Matthew, Jawad, Danielle, Lazarus, Jeffrey V, Matthews, Gail V, Scheibe, Andrew, Vickerman, Peter, Dore, Gregory J, and Grebely, Jason
- Published
- 2024
- Full Text
- View/download PDF
5. Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
- Author
-
Singh, Kasha P., Avihingsanon, Anchalee, Zerbato, Jennifer M., Zhao, Wei, Braat, Sabine, Tennakoon, Surekha, Rhodes, Ajantha, Matthews, Gail V., Fairley, Christopher K., Sasadeusz, Joe, Crane, Megan, Audsley, Jennifer, and Lewin, Sharon R.
- Published
- 2024
- Full Text
- View/download PDF
6. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
- Author
-
Hellard, Margaret E, Sacks-Davis, Rachel, van Santen, Daniela K, Stewart, Ashleigh, Ke, Tianhui, Zhang, Yanqin, Stoove, Mark, Guy, Rebecca, Pedrana, Alisa, Asselin, Jason, Dawe, Joshua, Wilkinson, Anna, Boyd, Anders, Smit, Colette, van der Valk, Marc, Schinkel, Janke, Wittkop, Linda, Salmon, Dominique, Sogni, Philippe, Esterle, Laure, Gilbert, Camille, Merchadou, Laurence, Gillet, Stephanie, Khan, Coralie, Bonnet, Fabrice, Leleux, Olivier, Le Marec, Fabien, Perrier, Adelaide, Matthews, Gail, Shaw, Ineke, Martinello, Marianne, Applegate, Tanya, Carson, Joanne, Doyle, Joseph S, Harney, Brendan, Bryant, Melissa, Jarrin Vera, Inmaculada, Berenguer, Juan, Alejos, Belen, Lazarus, Jeffrey V, Moreno, Cristina, Izquierdo, Rebecca, Rava, Marta, Klein, Marina, Wang, Shouao, Lumia, Jessica, Pexos, Costa, Peiris, Hansi, Saeed, Sahar, Moodie, Erica, Young, Jim, Pick, Neora, Conway, Brian, Hull, Mark, Wong, Alex, Gill, John, Barrett, Lisa, Cohen, Jeff, Cox, Joseph, Cote, Pierre, Haider, Shariq, Rouleau, Danielle, Vachon, Marie-Louise, Rachlis, Anita, Sandre, Roger, Walmsley, Sharon, Sadr, Aida, Cooper, Curtis, Sanche, Steve, Rauch, Andri, Mugglin, Catrina, Salazar-Viscaya, Luisa, Kusejko, Katharina, Prins, Maria, Hage, Kris, Lacombe, Karine, Requena, Maria-Bernada, Girard, Pierre-Marie, Brucker, Matthieu, Vincensini, Jean-Paul, Jarrin, Inmaculada, Requena, Maria-Bernarda, Matthews, Gail V, Martin, Natasha K, Spelman, Tim, and Hellard, Margaret
- Published
- 2024
- Full Text
- View/download PDF
7. Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
- Author
-
Martinello, Marianne, Bhagani, Sanjay, Shaw, David, Orkin, Chloe, Cooke, Graham, Gane, Edward, Iser, David, Ustianowski, Andrew, Kulasegaram, Ranjababu, Stedman, Catherine, Tu, Elise, Grebely, Jason, Dore, Gregory J., Nelson, Mark, and Matthews, Gail V.
- Published
- 2023
- Full Text
- View/download PDF
8. National trends in retreatment of HCV due to reinfection or treatment failure in Australia
- Author
-
Carson, Joanne M., Barbieri, Sebastiano, Matthews, Gail V., Dore, Gregory J., and Hajarizadeh, Behzad
- Published
- 2023
- Full Text
- View/download PDF
9. Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study
- Author
-
Marshall, Alison D., Martinello, Marianne, Treloar, Carla, and Matthews, Gail V.
- Published
- 2022
- Full Text
- View/download PDF
10. Reinfection incidence and risk among people treated for recent hepatitis C virus infection
- Author
-
Martinello, Marianne, Carson, Joanne M., Van Der Valk, Marc, Rockstroh, Jürgen K., Ingiliz, Patrick, Hellard, Margaret, Nelson, Mark, Lutz, Thomas, Bhagani, Sanjay, Kim, Arthur Y., Hull, Mark, Cordes, Christiane, Moon, Juhi, Feld, Jordan J., Gane, Ed, Rauch, Andri, Bruneau, Julie, Tu, Elise, Applegate, Tanya, Grebely, Jason, Dore, Gregory J., and Matthews, Gail V.
- Published
- 2023
- Full Text
- View/download PDF
11. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
- Author
-
Aggarwal, Anupriya, Stella, Alberto Ospina, Walker, Gregory, Akerman, Anouschka, Esneau, Camille, Milogiannakis, Vanessa, Burnett, Deborah L., McAllery, Samantha, Silva, Mariana Ruiz, Lu, Yonghui, Foster, Charles S. P., Brilot, Fabienne, Pillay, Aleha, Van Hal, Sabastiaan, Mathivanan, Vennila, Fichter, Christina, Kindinger, Andrea, Hoppe, Alexandra Carey, Munier, Mee Ling, Amatayakul-Chantler, Supavadee, Roth, Nathan, Coppola, Germano, Symonds, Geoff P., Schofield, Peter, Jackson, Jennifer, Lenthall, Helen, Henry, Jake Y., Mazigi, Ohan, Jäck, Hans-Martin, Davenport, Miles P., Darley, David R., Matthews, Gail V., Khoury, David S., Cromer, Deborah, Goodnow, Christopher C., Christ, Daniel, Robosa, Roselle, Starck, Damien J., Bartlett, Nathan W., Rawlinson, William D., Kelleher, Anthony D., and Turville, Stuart G.
- Published
- 2022
- Full Text
- View/download PDF
12. Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults
- Author
-
He, Wen-Qiang, Matthews, Gail V., and Liu, Bette
- Published
- 2022
- Full Text
- View/download PDF
13. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression
- Author
-
Hosseini-Hooshyar, Samira, Hajarizadeh, Behzad, Bajis, Sahar, Law, Matthew, Janjua, Naveed Z, Fierer, Daniel S, Chromy, David, Rockstroh, Jürgen K, Martin, Thomas C S, Ingiliz, Patrick, Hung, Chien-Ching, Dore, Gregory J, Martinello, Marianne, and Matthews, Gail V
- Published
- 2022
- Full Text
- View/download PDF
14. Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort.
- Author
-
Harney, Brendan L., Sacks‐Davis, Rachel, van Santen, Daniela K., Stewart, Ashleigh C., Matthews, Gail V., Carson, Joanne M., Klein, Marina B., Lacombe, Karine, Wittkop, Linda, Salmon, Dominque, Leleux, Olivier, Merchadou, Laurence, van der Valk, Marc, Smit, Colette, Prins, Maria, Boyd, Anders, Berenguer, Juan, Jarrin, Inmaculada, Rauch, Andri, and Hellard, Margaret E.
- Subjects
DRUG abuse ,END of treatment ,HEPATITIS C virus ,HEPATITIS C ,TREATMENT effectiveness - Abstract
Background: Historically, hepatitis C virus (HCV) was difficult to treat among people with HIV. However, treatment with direct‐acting antivirals (DAAs) results in 90%–95% of people being cured. There is a need to understand why a proportion of people are not cured. We aimed to examine characteristics that may indicate an increased probability of unsuccessful DAA HCV treatment. Methods: Data were from the International Collaboration on Hepatitis C Elimination in HIV Cohorts. People who commenced DAA HCV treatment between 2014 and 2019 were included. Unsuccessful treatment was defined as a positive HCV RNA test at a person's first RNA test at least 4 weeks (SVR4+) following the end of treatment. Multivariable mixed‐effects logistic regression was used to examine characteristics associated with unsuccessful treatment. Results: Of 4468 people who commenced DAA treatment, 4098 (91.7%) had an SVR test 4+ weeks following the end of treatment, 207 (5%) of whom were unsuccessfully treated. Compared to a CD4+ cell count > 500 cells/mm3, cell counts < 200 (aOR 1.81, 95%CI 1.00–3.29) and between 200 and 349 (aOR 1.95, 95%CI 1.30–2.93) were associated with increased odds of unsuccessful treatment. Among 1921 people with data on injection drug use in the 12 months prior to treatment, there was some evidence that recent injection drug use was associated with increased odds of unsuccessful treatment; however, this was not statistically significant (aOR 1.67, 95%CI 0.99–2.82). Conclusions: The overwhelming majority of people were successfully treated for HCV. Overall, 5% of those with an SVR4+ test were unsuccessfully treated; this was more likely among people with evidence of immunodeficiency and those who reported recently injecting drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF
15. Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014–2023).
- Author
-
Martinello, Marianne, Carson, Joanne M, Post, Jeffrey J, Finlayson, Robert, Baker, David, Read, Phillip, Shaw, David, Bloch, Mark, Doyle, Joseph, Hellard, Margaret, Filep, Ecaterina, Hosseini-Hooshyar, Samira, Dore, Gregory J, and Matthews, Gail V
- Subjects
HEPATITIS C virus ,BISEXUAL men ,HIV-positive persons ,HEPATITIS C ,GAY men - Abstract
Background Approximately 10% of people with HIV in Australia had active hepatitis C virus (HCV) infection prior to availability of government-subsidized direct-acting antiviral (DAA) therapy in 2016. This analysis evaluated progress toward HCV elimination among people with HIV in Australia between 2014 and 2023. Methods The CEASE cohort study enrolled adults with HIV with past or current HCV infection (anti-HCV antibody positive) from 14 primary and tertiary clinics. Biobehavioral, clinical, and virologic data were collected at enrollment (2014–2016), follow-up 1 (2017–2018), and follow-up 2 (2021–2023). HCV treatment uptake, outcome, and HCV RNA prevalence (current infection) were evaluated. Death and HCV reinfection incidence and risk were assessed. Results Of 402 participants, 341 (85%) had current HCV infection (RNA positive) at enrollment. Among the sample, 83% were gay and bisexual men, 13% had cirrhosis, and 80% had a history of injecting drug use (42%, past 6 months). DAA treatment was scaled up rapidly, with cumulative treatment uptake increasing from 12% in 2014 to 2015 to 92% in 2022 to 2023. HCV RNA prevalence declined from 85% (95% CI, 81%–88%) at enrollment (2014–2016) to 8% (95% CI, 6%–12%) at follow-up 1 (2017–2018) and 0.5% (95% CI, 0%–3%) at follow-up 2 (2020–2023). Sixteen reinfections occurred (incidence, 1.41 per 100 person-years; 95% CI,.81–2.29) as well as 30 deaths (incidence, 1.64 per 100 person-years; 95% CI, 1.11–2.34). HCV reinfection incidence declined over time while mortality remained stable. Conclusions Universal access and rapid DAA uptake were associated with a dramatic reduction in HCV prevalence and reinfection incidence among people with HIV to levels consistent with microelimination. Registration: NCT02102451 (ClinicalTrials.gov). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
- Author
-
Phetsouphanh, Chansavath, Darley, David R., Wilson, Daniel B., Howe, Annett, Munier, C. Mee Ling, Patel, Sheila K., Juno, Jennifer A., Burrell, Louise M., Kent, Stephen J., Dore, Gregory J., Kelleher, Anthony D., and Matthews, Gail V.
- Published
- 2022
- Full Text
- View/download PDF
17. Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study
- Author
-
Nyein, Phyo Pyae, primary, Petoumenos, Kathy, additional, Borok, Margaret, additional, Eriobu, Nnakelu, additional, Kumarasamy, Nagalingeswaran, additional, Avihingsanon, Anchalee, additional, Azwa, Iskandar, additional, Dao, Sounkalo, additional, Cisse, Mohamed, additional, Dharan, Nila J, additional, Hanson, Josh, additional, and Matthews, Gail V, additional
- Published
- 2024
- Full Text
- View/download PDF
18. Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
- Author
-
van der Valk, Marc, Hellard, Margaret, Gane, Ed, Rauch, Andri, Bruneau, Julie, Kim, Arthur, Bhagani, Sanjay, Dore, Greg, Marks, Pip, Matthews, Gail, Grebely, Jason, Petoumenos, Kathy, Martinello, Marianne, Applegate, Tanya, Feld, Jordan, Rockstroh, Jürgen, Amjad, Sophia, Tu, Elise, Tamaddoni, Mahshid, Thurnheer, Maria Christine, Gilleece, Yvonne, Nelson, Mark, Fraser, Chris, Moriggia, Alberto, Lutz, Thomas, Moon, Juhi, Read, Phillip, Kim, Arthur Y., Ustianowski, Andrew, Cordes, Christiane, Shaw, David, Sasadeusz, Joe, Hull, Mark, Braun, Dominique, Ingiliz, Patrick, Matthews, Gail V., Van der Valk, Marc, Rockstroh, Juergen, Feld, Jordan J., Thurnheer, Christine, Applegate, Tanya L., Marks, Phillipa, and Dore, Gregory J.
- Published
- 2021
- Full Text
- View/download PDF
19. A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies
- Author
-
Bartlett, Sofia R, Wertheim, Joel O, Bull, Rowena A, Matthews, Gail V, Lamoury, Francois Mj, Scheffler, Konrad, Hellard, Margaret, Maher, Lisa, Dore, Gregory J, Lloyd, Andrew R, Applegate, Tanya L, and Grebely, Jason
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Clinical Sciences ,Infectious Diseases ,Liver Disease ,Hepatitis ,Digestive Diseases ,Prevention ,Sexually Transmitted Infections ,Chronic Liver Disease and Cirrhosis ,HIV/AIDS ,Emerging Infectious Diseases ,Hepatitis - C ,5.1 Pharmaceuticals ,2.2 Factors relating to the physical environment ,6.1 Pharmaceuticals ,Infection ,Good Health and Well Being ,Adult ,Antiviral Agents ,Australia ,Cluster Analysis ,Disease Transmission ,Infectious ,Female ,Genotype ,HIV Infections ,Hepacivirus ,Hepatitis C ,Humans ,Male ,Middle Aged ,Molecular Epidemiology ,Phylogeny ,Sequence Analysis ,DNA ,Treatment Outcome ,Young Adult ,hepatitis C virus ,human immunodeficiency virus ,modelling ,molecular epidemiology ,treatment as prevention ,Microbiology ,Gastroenterology & Hepatology ,Clinical sciences ,Medical microbiology - Abstract
Combining phylogenetic and network methodologies has the potential to better inform targeted interventions to prevent and treat infectious diseases. This study reconstructed a molecular transmission network for people with recent hepatitis C virus (HCV) infection and modelled the impact of targeting directly acting antiviral (DAA) treatment for HCV in the network. Participants were selected from three Australian studies of recent HCV from 2004 to 2014. HCV sequence data (Core-E2) from participants at the time of recent HCV detection were analysed to infer a network by connecting pairs of sequences whose divergence was ≤.03 substitutions/site. Logistic regression was used to identify factors associated with connectivity. Impact of targeting HCV DAAs at both HIV co-infected and random nodes was simulated (1 million replicates). Among 236 participants, 21% (n=49) were connected in the network. HCV/HIV co-infected participants (47%) were more likely to be connected compared to HCV mono-infected participants (16%) (OR 4.56; 95% CI; 2.13-9.74). Simulations targeting DAA HCV treatment to HCV/HIV co-infected individuals prevented 2.5 times more onward infections than providing DAAs to randomly selected individuals. Results demonstrate that genetic distance-based network analyses can be used to identify characteristics associated with HCV transmission, informing targeted prevention and treatment strategies.
- Published
- 2017
20. High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia
- Author
-
Valerio, Heather, Alavi, Maryam, Law, Matthew, Tillakeratne, Shane, Amin, Janaki, Janjua, Naveed Z., Krajden, Mel, George, Jacob, Matthews, Gail V., Hajarizadeh, Behzad, Degenhardt, Louisa, Grebely, Jason, and Dore, Gregory J.
- Published
- 2021
- Full Text
- View/download PDF
21. Modeling based response guided therapy in subjects with recent hepatitis C infection
- Author
-
Gorstein, Evan, Martinello, Marianne, Churkin, Alexander, Dasgupta, Swikriti, Walsh, Kevin, Applegate, Tanya L., Yardeni, David, Etzion, Ohad, Uprichard, Susan L., Barash, Danny, Cotler, Scott J., Matthews, Gail V., and Dahari, Harel
- Published
- 2020
- Full Text
- View/download PDF
22. Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial
- Author
-
Dore, Gregory J., Feld, Jordan J., Thompson, Alex, Martinello, Marianne, Muir, Andrew J., Agarwal, Kosh, Müllhaupt, Beat, Wedemeyer, Heiner, Lacombe, Karine, Matthews, Gail V., Schultz, Michael, Klein, Marina, Hezode, Christophe, Mercade, Gerard Estivill, Kho, Danny, Petoumenos, Kathy, Marks, Philippa, Tatsch, Fernando, Dos Santos, Ana Gabriela Pires, and Gane, Ed
- Published
- 2020
- Full Text
- View/download PDF
23. Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020
- Author
-
Harney, Brendan L, primary, Sacks-Davis, Rachel, additional, Agius, Paul, additional, van Santen, Daniela K, additional, Traeger, Michael W, additional, Wilkinson, Anna L, additional, Asselin, Jason, additional, Fairley, Christopher K, additional, Roth, Norman, additional, Bloch, Mark, additional, Matthews, Gail V, additional, Donovan, Basil, additional, Guy, Rebecca, additional, Stoové, Mark, additional, Hellard, Margaret E, additional, and Doyle, Joseph S, additional
- Published
- 2024
- Full Text
- View/download PDF
24. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
- Author
-
Marshall, Alison D, primary, Willing, Alex R, additional, Kairouz, Abe, additional, Cunningham, Evan B, additional, Wheeler, Alice, additional, O’Brien, Nicholas, additional, Perera, Vidura, additional, Ward, John W, additional, Hiebert, Lindsey, additional, Degenhardt, Louisa, additional, Hajarizadeh, Behzad, additional, Colledge, Samantha, additional, Hickman, Matthew, additional, Jawad, Danielle, additional, Lazarus, Jeffrey V, additional, Matthews, Gail V, additional, Scheibe, Andrew, additional, Vickerman, Peter, additional, Dore, Gregory J, additional, Grebely, Jason, additional, Sargsyants, N., additional, Suleymanova, L., additional, Salkic, N., additional, Simonova, M., additional, Nemeth-Blazic, T., additional, Mravcik, V., additional, Kivimets, K., additional, Salupere, R., additional, Butsashvili, M., additional, Soselia, G., additional, Makara, M., additional, Tolmane, I., additional, Jancorienė, L., additional, Stratulat, S., additional, Flisiak, R., additional, Gheorghe, L., additional, Cernat, R., additional, Lakhov, A., additional, Stanevich, O., additional, Jarcuska, P., additional, Peck-Radosavljevic, M., additional, Robaeys, G., additional, Øvrehus, A., additional, Foster, G., additional, Sutinen, J., additional, Farkkila, M., additional, Rautiainen, H., additional, Vuoti, S., additional, Nikolova, D., additional, Pawlotsky, J.M., additional, Rockstroh, J., additional, Sypsa, V., additional, Papatheodoridis, G., additional, Olafsson, S., additional, Feeney, E., additional, Teti, E., additional, Seguin-Devaux, C., additional, Pocock, J., additional, Reiff, S., additional, McDougall, N., additional, Van der Valk, M., additional, Dalgard, O., additional, Tato Marinho, R., additional, Dillon, J., additional, Peters, E., additional, Bojovic, K., additional, Matičič, M., additional, Kåberg, M., additional, Bruggmann, P., additional, Healy, B., additional, Chong, V.H., additional, Yi, S., additional, Tucker, J., additional, Pasaribu, L.R., additional, Tanaka, J., additional, Ashley, E.A., additional, Abu Hassan, M.R., additional, Mohammed, N.S., additional, Chan, H.K., additional, Gidaagaya, S., additional, Kyi, K.P., additional, Hyung Joon, K., additional, Chin, B., additional, Baladjay, P.C., additional, Kao, J.H., additional, Wansom, T., additional, da Cruz, B., additional, Flower, B., additional, Ehsan, E., additional, Al Mahtab, M., additional, Khandu, L., additional, Bhadoria, A.S., additional, Alavi, M., additional, KC, P., additional, Hamid, S., additional, Biryukov, S., additional, Alymbaeva, D., additional, Alaei, A., additional, Bakieva, S., additional, Flichman, D., additional, Carmo, R.F., additional, Valdez, E., additional, Cortes, C.P., additional, Contreras, F., additional, Teran, E., additional, Velez-Moller, P., additional, Jagnarine, T., additional, Mills, M., additional, Goodman-Meza, D., additional, Sánchez, J., additional, Montenegro-Idrogo, J.J., additional, Lugo Canales, A.M., additional, Davy, J., additional, Alexander, A., additional, Gerona, S., additional, Perazzo, R., additional, Balak, D., additional, Kelly-Hanku, A., additional, Fineanganofo, A., additional, Gane, E., additional, Raymond, N., additional, Debzi, N., additional, Sridharan, K., additional, Waked, I., additional, Turner, D., additional, Shibolet, O., additional, Al Muzaini, A., additional, El Nakib, M., additional, Sheriff, D.S., additional, Brahni, T., additional, Essayagh, T., additional, Essayagh, S., additional, Hjaija, D., additional, Al-Naamani, K., additional, Sanai, F.M., additional, Pasquale, H., additional, Bedri, S., additional, Chakroun, M., additional, Ghrabi, A., additional, Akarca, U.S., additional, Falcao, V., additional, Edmond Gbedo, S., additional, Ouoba, S., additional, Nyabenda, F., additional, Rocher Mbella, M., additional, Mahamat Moussa, A., additional, Youssouf, T., additional, Boniface, Y., additional, Akilimali Shindano, T., additional, Hamida, M.E., additional, Mongo, A., additional, Mapapa, C., additional, Desalegn, H., additional, Embinga, E.L.A., additional, Ndow, G., additional, Nartey, Y., additional, Cisse, M., additional, Djalo, M.A., additional, Mugambi, M., additional, Nyakowa, M., additional, Jeuronlon, M.K., additional, Ngoma, J., additional, Manitrala Ramanampamonjy, R., additional, Naik, K., additional, Soyjaudah, M.D., additional, Filipe, E., additional, Nnakelu, E., additional, Serumondo, J., additional, Mbodj, M., additional, Patino, M., additional, Aalto, M.K., additional, Waweru, P., additional, Dagnra, A., additional, Ocama, P., additional, Maghimbi, A., additional, Hamooya, B.M., additional, Katsidzira, L., additional, Rios, C., additional, Thormann, M., additional, Al Marzooqi, N., additional, Al Rand, H.M., additional, Francois, K., additional, Hamoudi, W., additional, Alkharty, M., additional, Skripo, O., additional, and Uka, T., additional
- Published
- 2024
- Full Text
- View/download PDF
25. Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)]
- Author
-
Bin Usman Shah, Syed Hassan, primary, Alavi, Maryam, additional, Hajarizadeh, Behzad, additional, Matthews, Gail V., additional, Martinello, Marianne, additional, Danta, Mark, additional, Amin, Janaki, additional, Law, Matthew G., additional, George, Jacob, additional, Valerio, Heather, additional, and Dore, Gregory J., additional
- Published
- 2024
- Full Text
- View/download PDF
26. How I manage severe bacterial infections in people who inject drugs
- Author
-
Stewardson, Andrew J., primary, Davis, Joshua S., additional, Dunlop, Adrian J., additional, Tong, Steven Y.C., additional, and Matthews, Gail V., additional
- Published
- 2024
- Full Text
- View/download PDF
27. Cure and Control: What Will It Take to Eliminate HCV?
- Author
-
Martinello, Marianne, Hajarizadeh, Behzad, Grebely, Jason, Matthews, Gail V., Dore, Gregory J., Bernstein, Peter R., Series Editor, Garner, Amanda L., Series Editor, Georg, Gunda I., Series Editor, Lowe, John A., Series Editor, Meanwell, Nicholas A., Series Editor, Saxena, Anil Kumar, Series Editor, Supuran, Claudiu T., Series Editor, Zhang, Ao, Series Editor, and Sofia, Michael J., editor
- Published
- 2019
- Full Text
- View/download PDF
28. Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE study
- Author
-
Han, Win Min, Sazzad, Hossain M.S., Bloch, Mark, Winter, Diana, Baker, David, Roth, Norman, Lau, Helen, Smith, Don, Acklom, Kathryn, Hoy, Jennifer F., Price, Sally, Woolley, Ian, O’Bryan, Jessica, Finlayson, Robert, Templeton, David J., Sinclair, Brett, Matthews, Gail, Costello, Jane, Dawson, Mark A., Dawson, Sarah-Jane, Polizzotto, Mark N., Petoumenos, Kathy, Yeh, Paul, Dharan, Nila J., Baker, David A., Bowden-Reid, Ellen, Smith, Don E., and Matthews, Gail V.
- Published
- 2024
- Full Text
- View/download PDF
29. A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections
- Author
-
Olmstead, Andrea D., Montoya, Vincent, Chui, Celia K., Dong, Winnie, Joy, Jeffrey B., Tai, Vera, Poon, Art F.Y., Nguyen, Thuy, Brumme, Chanson J., Martinello, Marianne, Matthews, Gail V., Richard Harrigan, P., Dore, Gregory J., Applegate, Tanya L., Grebely, Jason, and Howe, Anita Y.M.
- Published
- 2019
- Full Text
- View/download PDF
30. Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020
- Author
-
Harney, Brendan L., primary, Sacks‐Davis, Rachel, additional, van Santen, Daniela K., additional, Traeger, Michael W., additional, Wilkinson, Anna L., additional, Asselin, Jason, additional, Fairley, Christopher K., additional, Roth, Norman, additional, Bloch, Mark, additional, Matthews, Gail V., additional, Donovan, Basil, additional, Guy, Rebecca, additional, Stoové, Mark, additional, Hellard, Margaret E., additional, and Doyle, Joseph S., additional
- Published
- 2024
- Full Text
- View/download PDF
31. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
- Author
-
Sacks-Davis, Rachel, primary, van Santen, Daniela K, additional, Boyd, Anders, additional, Young, Jim, additional, Stewart, Ashleigh, additional, Doyle, Joseph S, additional, Rauch, Andri, additional, Mugglin, Catrina, additional, Klein, Marina, additional, van der Valk, Marc, additional, Smit, Colette, additional, Jarrin, Inmaculada, additional, Berenguer, Juan, additional, Lacombe, Karine, additional, Requena, Maria-Bernarda, additional, Wittkop, Linda, additional, Leleux, Olivier, additional, Bonnet, Fabrice, additional, Salmon, Dominique, additional, Matthews, Gail V, additional, Guy, Rebecca, additional, Martin, Natasha K, additional, Spelman, Tim, additional, Prins, Maria, additional, Stoove, Mark, additional, Hellard, Margaret, additional, Hellard, Margaret E, additional, Sacks-Davis, Rachel, additional, Ke, Tianhui, additional, Zhang, Yanqin, additional, Pedrana, Alisa, additional, Asselin, Jason, additional, Dawe, Joshua, additional, Wilkinson, Anna, additional, Schinkel, Janke, additional, Sogni, Philippe, additional, Esterle, Laure, additional, Gilbert, Camille, additional, Merchadou, Laurence, additional, Gillet, Stephanie, additional, Khan, Coralie, additional, Le Marec, Fabien, additional, Perrier, Adelaide, additional, Matthews, Gail, additional, Shaw, Ineke, additional, Martinello, Marianne, additional, Applegate, Tanya, additional, Carson, Joanne, additional, Harney, Brendan, additional, Bryant, Melissa, additional, Jarrin Vera, Inmaculada, additional, Alejos, Belen, additional, Lazarus, Jeffrey V, additional, Moreno, Cristina, additional, Izquierdo, Rebecca, additional, Rava, Marta, additional, Wang, Shouao, additional, Lumia, Jessica, additional, Pexos, Costa, additional, Peiris, Hansi, additional, Saeed, Sahar, additional, Moodie, Erica, additional, Pick, Neora, additional, Conway, Brian, additional, Hull, Mark, additional, Wong, Alex, additional, Gill, John, additional, Barrett, Lisa, additional, Cohen, Jeff, additional, Cox, Joseph, additional, Cote, Pierre, additional, Haider, Shariq, additional, Rouleau, Danielle, additional, Vachon, Marie-Louise, additional, Rachlis, Anita, additional, Sandre, Roger, additional, Walmsley, Sharon, additional, Sadr, Aida, additional, Cooper, Curtis, additional, Sanche, Steve, additional, Salazar-Viscaya, Luisa, additional, Kusejko, Katharina, additional, Hage, Kris, additional, Requena, Maria-Bernada, additional, Girard, Pierre-Marie, additional, Brucker, Matthieu, additional, and Vincensini, Jean-Paul, additional
- Published
- 2024
- Full Text
- View/download PDF
32. Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study.
- Author
-
Valerio, Heather, Alavi, Maryam, Marshall, Alison D., Hajarizadeh, Behzad, Amin, Janaki, Law, Matthew, Tillakeratne, Shane, George, Jacob, Degenhardt, Louisa, Grebely, Jason, Matthews, Gail V., and Dore, Gregory J.
- Subjects
CHILDBEARING age ,HEPATITIS C ,INDIGENOUS Australians ,DRUG addiction ,HEPATITIS C virus - Abstract
Introduction: Females of childbearing age with hepatitis C virus (HCV) face increased marginalisation with intersecting, sex‐specific barriers to direct acting antiviral (DAA) therapy. We assessed the factors associated with uptake of DAA therapy among females of childbearing age, including those with evidence of recent drug dependence. Methods: HCV notifications in New South Wales, Australia (1995–2017) were linked to opioid agonist therapy (OAT), hospitalisations, incarcerations, perinatal, HIV notifications, deaths and prescription databases. Recent drug dependence was defined as hospitalisation due to injectable drugs or receipt of OAT occurring in the DAA era (2016–2018). Logistic regression was used to analyse factors associated with DAA uptake among females of childbearing age (18–44), including those with recent drug dependence. Results: Among 57,467 people with evidence of chronic HCV in the DAA era (2016–2018), 20,161 (35%) were female, including 33% (n = 6563/20,161) of childbearing age (18–44). Among all females of childbearing age (n = 6563) and those with evidence of recent drug dependence (n = 2278/6563, 35%), DAA uptake was lower among those who had given birth in the DAA era (vs. no birth record, all females of childbearing age; aOR: 0.74, 95% CI 0.61, 0.89; those with recent drug dependence; aOR 0.69, 95% CI 0.51, 0.93) and Aboriginal and Torres Strait Islander peoples (all females of childbearing age; aOR 0.81, 95% CI 0.71, 0.93; those with recent drug dependence aOR 0.75, 95% CI 0.62, 0.90). Conclusion: Females of childbearing age should be considered a key population for DAA therapy. Enhancing antenatal and postnatal HCV care may be critical in the pursuit towards elimination. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. The APPRISE Virtual Biobank for Infectious Diseases
- Author
-
Smith, Miranda Z, primary, Turner, Maureen, additional, Haurat, Javier, additional, Thevarajan, Irani, additional, Denholm, Justin, additional, Tong, Steven YC, additional, Matthews, Gail V, additional, Bull, Rowena A, additional, Martinello, Marianne, additional, McMahon, James, additional, Imrie, Allison, additional, and Pillai, Priyanka E, additional
- Published
- 2023
- Full Text
- View/download PDF
34. Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
- Author
-
Grebely, Jason, Conway, Brian, Cunningham, Evan B., Fraser, Chris, Moriggia, Alberto, Gane, Ed, Stedman, Catherine, Cooper, Curtis, Castro, Erika, Schmid, Patrick, Petoumenos, Kathy, Hajarizadeh, Behzad, Marks, Phillipa, Erratt, Amanda, Dalgard, Olav, Lacombe, Karine, Feld, Jordan J., Bruneau, Julie, Daulouede, Jean-Pierre, Powis, Jeff, Bruggmann, Philip, Matthews, Gail V., Kronborg, Ian, Shaw, David, Dunlop, Adrian, Hellard, Margaret, Applegate, Tanya L., Crawford, Sione, and Dore, Gregory J
- Published
- 2018
- Full Text
- View/download PDF
35. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
- Author
-
Cunningham, Evan B., Amin, Janaki, Feld, Jordan J., Bruneau, Julie, Dalgard, Olav, Powis, Jeff, Hellard, Margaret, Cooper, Curtis, Read, Phillip, Conway, Brian, Dunlop, Adrian J., Norton, Briana, Litwin, Alain H., Hajarizadeh, Behzad, Thurnheer, Maria Christine, Dillon, John F., Weltman, Martin, Shaw, David, Bruggmann, Philip, Gane, Edward, Fraser, Chris, Marks, Philippa, Applegate, Tanya L., Quiene, Sophie, Siriragavan, Sharmila, Matthews, Gail V., Dore, Gregory J., and Grebely, Jason
- Published
- 2018
- Full Text
- View/download PDF
36. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs
- Author
-
Martinello, Marianne, Dore, Gregory J., Matthews, Gail V., and Grebely, Jason
- Published
- 2018
- Full Text
- View/download PDF
37. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
- Author
-
Grebely, Jason, Dalgard, Olav, Conway, Brian, Cunningham, Evan B, Bruggmann, Philip, Hajarizadeh, Behzad, Amin, Janaki, Bruneau, Julie, Hellard, Margaret, Litwin, Alain H, Marks, Philippa, Quiene, Sophie, Siriragavan, Sharmila, Applegate, Tanya L, Swan, Tracy, Byrne, Jude, Lacalamita, Melanie, Dunlop, Adrian, Matthews, Gail V, Powis, Jeff, Shaw, David, Thurnheer, Maria Christine, Weltman, Martin, Kronborg, Ian, Cooper, Curtis, Feld, Jordan J, Fraser, Chris, Dillon, John F, Read, Phillip, Gane, Ed, and Dore, Gregory J
- Published
- 2018
- Full Text
- View/download PDF
38. A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015
- Author
-
Bartlett, Sofia R., Applegate, Tanya L., Jacka, Brendan P., Martinello, Marianne, Lamoury, Francois M.J., Danta, Mark, Bradshaw, Daniel, Shaw, David, Lloyd, Andrew R., Hellard, Margaret, Dore, Gregory J., Matthews, Gail V., and Grebely, Jason
- Subjects
Prevalence studies (Epidemiology) -- Analysis ,Disease transmission -- Prevention ,Hepatitis C virus -- Care and treatment -- Patient outcomes ,Antibodies -- Usage ,Health - Abstract
Introduction: Over the last two decades, the incidence of hepatitis C virus (HCV) co-infection among men who have sex with men (MSM) living with HIV began increasing in post-industrialized countries. Little is known about transmission of acute or recent HCV, in particular among MSM living with HIV co-infection, which creates uncertainty about potential for reinfection after HCV treatment. Using phylogenetic methods, clinical, epidemiological and molecular data can be combined to better understand transmission patterns. These insights may help identify strategies to reduce reinfection risk, enhancing effectiveness of HCV treatment as prevention strategies. The aim of this study was to identify multi-risk profiles and factors associated with phylogenetic pairs and clusters among people with recent HCV infection. Methods: Data and specimens from five studies of recent HCV in Australia and New Zealand (2004 to 2015) were used. HCV Core-E2 sequences were used to infer maximum likelihood trees. Clusters were identified using 90% bootstrap and 5% genetic distance threshold. Multivariate logistic regression and latent class analyses were performed. Results: Among 237 participants with Core-E2 sequences, 47% were in a pair/cluster. Among HIV/HCV co-infected participants, 60% (74/123) were in a pair/cluster, compared to 30% (34/114) with HCV mono-infection (p < 0.001). HIV/HCV co-infection (vs. HCV mono-infection; adjusted odds ratio (AOR), 2.37, 95% confidence interval(CI), 1.45, 5.15) was independently associated with phylogenetic clustering. Latent class analysis identified three distinct risk profiles: (1) people who inject drugs, (2) HIV-positive gay and bisexual men (GBM) with low probability of injecting drug use (IDU) and (3) GBM with IDU & sexual risk behaviour. Class 2 (vs. Class 1, AOR 3.40; 95% CI, 1.52, 7.60), was independently associated with phylogenetic clustering. Many clusters displayed homogeneous characteristics, such as containing individuals exclusively from one city, individuals all with HIV/HCV co-infection or individuals sharing the same route of acquisition of HCV. Conclusions: Clusters containing individuals with specific characteristics suggest that HCV transmission occurs through discrete networks, particularly among HIV/HCV co-infected individuals. The greater proportion of clustering found among HIV/HCV co-infected participants highlights the need to provide broad direct-acting antiviral access encouraging rapid uptake in this population and ongoing monitoring of the phylogeny. Keywords: human immunodeficiency virus; hepatitis C virus; co-infection; phylogenetic clustering; latent class analysis; multi-risk profiles; gay and bisexual men; people who inject drugs, 1 | INTRODUCTION Globally, the prevalence and incidence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) is high, with approximately 42.4% to 62.1% of PWID estimated [...]
- Published
- 2019
- Full Text
- View/download PDF
39. Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case–Control Diagnostic Validation Study
- Author
-
Hage, Kris, primary, van de Kerkhof, Marita, additional, Boyd, Anders, additional, Carson, Joanne M., additional, Newsum, Astrid M., additional, Matser, Amy, additional, van der Valk, Marc, additional, Brinkman, Kees, additional, Arends, Joop E., additional, Lauw, Fanny N., additional, Rijnders, Bart J. A., additional, van Eeden, Arne, additional, Martinello, Marianne, additional, Matthews, Gail V., additional, Schinkel, Janke, additional, and Prins, Maria, additional
- Published
- 2023
- Full Text
- View/download PDF
40. Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia
- Author
-
Dharan, Nila J., primary, Sasson, Sarah C., additional, Ahlenstiel, Golo, additional, Andersen, Christopher R., additional, Bloch, Mark, additional, Buckland, Griselda, additional, Hamad, Nada, additional, Han, Win Min, additional, Kelleher, Anthony D., additional, Long, Georgina V., additional, Matthews, Gail V., additional, Mina, Michael M., additional, Papot, Emmanuelle, additional, Petoumenos, Kathy, additional, Swaminathan, Sanjay, additional, Withers, Barbara, additional, Yun, James, additional, and Polizzotto, Mark N., additional
- Published
- 2023
- Full Text
- View/download PDF
41. Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review
- Author
-
Martinello, Marianne, primary, Naggie, Susanna, additional, Rockstroh, Juergen Kurt, additional, and Matthews, Gail V, additional
- Published
- 2023
- Full Text
- View/download PDF
42. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection—Lessons for Functional HBV Cure?
- Author
-
Audsley, Jennifer, Avihingsanon, Anchalee, Littlejohn, Margaret, Bowden, Scott, Matthews, Gail V., Fairley, Christopher K., Lewin, Sharon R., and Sasadeusz, Joe
- Published
- 2020
- Full Text
- View/download PDF
43. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV
- Author
-
Hosseini-Hooshyar, Samira, Martinello, Marianne, Yee, Jasmine, Read, Phillip, Baker, David, Post, Jeffrey J., Finlayson, Robert, Bloch, Mark, Doyle, Joseph S., Shaw, David, Hellard, Margaret, Petoumenos, Kathy, Carson, Joanne, Dore, Gregory J., and Matthews, Gail V.
- Published
- 2020
- Full Text
- View/download PDF
44. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era
- Author
-
Sacks-Davis, Rachel, Doyle, Joseph S, Rauch, Andri, Beguelin, Charles, Pedrana, Alisa E, Matthews, Gail V, Prins, Maria, van der Valk, Marc, Klein, Marina B, Saeed, Sahar, Lacombe, Karine, Chkhartishvili, Nikoloz, Altice, Frederick L, and Hellard, Margaret E
- Subjects
HIV patients -- Health aspects ,Disease transmission -- Control ,Antiviral agents -- Dosage and administration ,Hepatitis C -- Care and treatment -- Risk factors -- Diagnosis ,Health - Abstract
Introduction: There is currently no published data on the effectiveness of DAA treatment for elimination of HCV infection in HIV-infected populations at a population level. However, a number of relevant studies and initiatives are emerging. This research aims to report cascade of care data for emerging HCV elimination initiatives and studies that are currently being evaluated in HIV/HCV co-infected populations in the context of implementation science theory. Methods: HCV elimination initiatives and studies in HIV co-infected populations that are currently underway were identified. Context, intervention characteristics and cascade of care data were synthesized in the context of implementation science frameworks. Results: Seven HCV elimination initiatives and studies were identified in HIV co-infected populations, mainly operating in high-income countries. Four were focused mainly on HCV elimination in HIV-infected gay and bisexual men (GBM), and three included a combination of people who inject drugs (PWID), GBM and other HIV-infected populations. None were evaluating treatment delivery in incarcerated populations. Overall, HCV RNA was detected in 4894 HIV-infected participants (range within studies: 297 to 994): 48% of these initiated HCV treatment (range: 21% to 85%; within studies from a period where DAAs were broadly available the total is 57%, range: 36% to 74%). Among studies with treatment completion data, 96% of 1109 initiating treatment completed treatment (range: 94% to 99%). Among those who could be assessed for sustained virological response at 12 weeks (SVR12), 1631 of 1757 attained SVR12 (93%, range: 86% to 98%). Conclusions: Early results from emerging research on HCV elimination in HIV-infected populations suggest that HCV treatment uptake is higher than reported levels prior to DAA treatment availability, but approximately half of patients remain untreated. These results are among diagnosed populations and additional effort is required to increase diagnosis rates. Among those who have initiated treatment, completion and SVR rates are promising. More data are required in order to evaluate the effectiveness of these elimination programmes in the long term, assess which intervention components are effective, and whether they need to be tailored to particular population groups. Keywords: hepatitis C virus; disease elimination; MSM; IDU; implementation science; barriers; cascade of care, 1 | INTRODUCTION Over two million people are estimated to be HIV/HCV coinfected globally [1]. Chronic viral hepatitis accounts for approximately 10% of mortality among people living with HIV [2]. [...]
- Published
- 2018
- Full Text
- View/download PDF
45. Management of acute HCV infection in the era of direct-acting antiviral therapy
- Author
-
Martinello, Marianne, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J., and Matthews, Gail V.
- Published
- 2018
- Full Text
- View/download PDF
46. The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC
- Author
-
Cysique, Lucette A., primary, Jakabek, David, additional, Bracken, Sophia G., additional, Allen‐Davidian, Yasmin, additional, Heng, Benjamin, additional, Chow, Sharron, additional, Dehhaghi, Mona, additional, Staats Pires, Ananda, additional, Darley, David R., additional, Byrne, Anthony, additional, Phetsouphanh, Chansavath, additional, Kelleher, Anthony, additional, Dore, Gregory J., additional, Matthews, Gail V., additional, Guillemin, Gilles J., additional, and Brew, Bruce J., additional
- Published
- 2023
- Full Text
- View/download PDF
47. Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study
- Author
-
Valerio, Heather, primary, Alavi, Maryam, additional, Marshall, Alison D., additional, Hajarizadeh, Behzad, additional, Amin, Janaki, additional, Law, Matthew, additional, Tillakeratne, Shane, additional, George, Jacob, additional, Degenhardt, Louisa, additional, Grebely, Jason, additional, Matthews, Gail V., additional, and Dore, Gregory J., additional
- Published
- 2023
- Full Text
- View/download PDF
48. Corrigendum to ‘National trends in retreatment of HCV due to reinfection or treatment failure in Australia’ (J Hepatol [2023] 260–270)
- Author
-
Carson, Joanne M., primary, Barbieri, Sebastiano, additional, Matthews, Gail V., additional, Dore, Gregory J., additional, and Hajarizadeh, Behzad, additional
- Published
- 2023
- Full Text
- View/download PDF
49. Hepatitis C treatment as prevention: evidence, feasibility, and challenges
- Author
-
Hajarizadeh, Behzad, Grebely, Jason, Martinello, Marianne, Matthews, Gail V, Lloyd, Andrew R, and Dore, Gregory J
- Published
- 2016
- Full Text
- View/download PDF
50. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014)
- Author
-
Waziry, Reem, Grebely, Jason, Amin, Janaki, Alavi, Maryam, Hajarizadeh, Behzad, George, Jacob, Matthews, Gail V., Law, Matthew, and Dore, Gregory J.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.